Glutamate and Neurodegenerative Disease-Reference-Cited by-同舟云学术

Glutamate and Neurodegenerative Disease

Published:2010 Issue: Volume: Page:91-147
ISSN:1862-2461
Container-title:Topics in Medicinal Chemistry
language:
Short-container-title:

Author:

Schaeffer Eric,Duplantier Allen

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/7355_2010_11

Reference375 articles.

1. Liguz-Lecznar M, Skangiel-Kramska J (2007) Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system. Acta Neurobiol Exp 67:207–218

2. Bunch L, Erichsen MN, Jensen AA (2009) Excitatory amino acid transporters as potential drug targets. Expert Opin Ther Targets 13:719–731

3. Bowie D (2008) Ionotropic glutamate receptors & CNS disorders. CNS Neurol Disord Drug Targets 7:129–143

4. Lodge D (2009) The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology 56:6–21

5. Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295–322

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging in Vivo Glutamate Fluctuations with [11C]ABP688: A GLT-1 Challenge with Ceftriaxone;Journal of Cerebral Blood Flow & Metabolism;2015-03-25

2. Thiazole: A promising heterocycle for the development of potent CNS active agents;European Journal of Medicinal Chemistry;2015-03

3. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD;Brain Structure and Function;2015-01-18

4. Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System;Nucleic Acid Therapeutics;2014-12